SMAD1 Antibody

Basic information

Name

SMAD1 Antibody

size

0.1ml

Catalog number

bs-16376R

Price

263 €

Extended information

Modification(s)

None

Gene ID number

4086

Target Antigen

SMAD1

Swiss Prot

Q15797

French translation

anticorps

Tested Applications

WB, IHC-P

Also known as

SMAD1 PAb

Immunogen range

185-220/465

Concentration

1ug per 1ul

Conjugation

Unconjugated

Cross reactivity

Human, Mouse, Rat

Category

Primary Antibodies

Subcellular location

Cytoplasm, Nucleus

Clone number

Polyclonal antibody

Modification site(s)

Unmodified antibody

Clonality

Polyclonal antibody

Recommended dilutions

WB(1:100-1000), IHC-P(1:100-500)

Long name

SMAD1 Primary Polyclonal Antibody

Purification method

This antibody was purified via Protein A.

Cross reactive species details

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

Source

This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human SMAD1

Specificity

This is a highly specific antibody against SMAD1. This antibody may cross react with AKAP6 due to a few animo acid sequence similarity.

Storage conditions

Keep the antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for up to 1 year.

Properties

If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Synonym names

BSP1; JV41; BSP-1; JV4-1; MADH1; MADR1; Mothers against decapentaplegic homolog 1; MAD homolog 1; Mothers against DPP homolog 1; Mad-related protein 1; SMAD family member 1; SMAD 1; Smad1; hSMAD1; Transforming growth factor-beta-signaling protein 1

Background of the target antigen

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.